On March 25, 2019 the seventh council of CCCMHPIE was held successfully in quanzhou of Fujian, TUL as the standing director was invited to participate the meeting.

  CCCMHPIE commended most outstanding enterprises who got excellent exporting and importing job for API, Formulations and Chinese Medicines in 2018.The United Laboratories international holdings Ltd., continue to obtain 「China TOP 10 Member Enterprises of APIs " which export volume ranks No.4.

  TUL obtained this award for many years with our own progress and hard work are inseparable, grasp market information, and adjust sales strategy timely, in the increasingly fierce market competition environment to maintain steady and fast growth, at the same time actively for industrial upgrading and transformation.

  Chinese customs statistics show that in 2018, our western medicine products export $36.883 billion, with an increase of 4.03%.Among them, the API exported $30.048 billion, up 3.20%.To the United States, EU, India and other major markets growth as 8.87%, 3.56% and 1.71% respectively, growth slowed. Compared with 2017, the main reason is the supply of API enterprise production capacity is relatively abundant, but weak external demand, export growth is restricted API.Overall, in 2018, the supply side structural reform drive export price, export seek improvement.

 In 2019, global API market is still full of crisis and challenge, pharmaceutical trade friction effect should not be ignored, and TUL will continue to optimize product structure, adhere to the international line remains the same. Deepen the communication channels in the same industry, integrate the resources, deepen global focus on medical market, and help western medicine raw material industry rapid growth of exports.